Gynecologic Cancer News

Ovarian cancer care costs are considerable, varying by care phase, age and geographic region, with the highest costs observed at initiation of and end-of-life care, researchers reported in the American Journal of Obstetrics and Gynecology.

The addition of pembrolizumab to adjuvant chemotherapy improved DFS for certain women with newly diagnosed high-risk endometrial cancer, according to randomized phase 3 study results presented at ESMO Congress.

The combination of pembrolizumab and chemoradiotherapy significantly improved OS for women with high-risk locally advanced cervical cancer, according to results of a randomized phase 3 trial presented at ESMO Congress.

Genital talc powder and frequent douching were associated with an increased risk for ovarian cancer, according to a recent study.

Endometrial hyperplasia and endometrial cancer have a low incidence for women with recurrent abnormal uterine bleeding, with predictive factors being older age, nulliparity, polyp history and shorter intervals between samplings, data show.

Spouses of people with cancer exhibited significantly higher risk for attempted suicide and suicide death than those whose spouses had not been diagnosed with cancer, according to a nationwide cohort study in Denmark.

The FDA expanded the approval of dostarlimab-gxly for treatment of endometrial cancer.

Incidence rates for 17 different cancer types increased for successively younger generations in the United States during the past century.

The addition of an investigational immunotherapy to chemotherapy prolonged survival for women with advanced ovarian cancer, according to a topline data announcement.